Canntab Therapeutics

Traded on the CSE under the ticker PILL. We have developed a product line of solid oral dose delivery systems including extended release (XR), flash melt, immediate release, modified release and bi-layered tablet solutions that provide a variety of cannabinoid and terpenoid blends in exacting dosages. A clear and sustainable competitive advantage with 13 patents pending. Working with Emblem Corp. in Canada and leveraging our joint venture with Queensland Bauxite to market in Australia and Asia, Canntab Therapeutics will be perfectly positioned in the growing wellness market. Two of our products having already received an NPN number from Health Canada. With the help of Lorne Gertner and other we intend to open up markets around the world and as Mr. Gertner says, “I believe the ultimate solution to the delivery of Cannabis will be through a hard pill.” We understand the growing cannabis health and wellness market and are positioned as the premier solution for medical oral dose administration. Safe, discreet, accurate and reliable. Lead by a team of professionals with the experience needed to bring these products to market.